Increased odds of using multiple sun protection measures among organ transplant recipients
WEDNESDAY, June 13, 2018 (HealthDay News) — For organ transplant recipients, participation in a skin cancer research study is associated with increased use of multiple sun protection behaviors, according to a research letter published online June 6 in JAMA Dermatology.
Rebecca I. Hartman, M.D., M.P.H., from Brigham and Women’s Hospital in Boston, and colleagues conducted a retrospective cohort study among kidney and liver transplant recipients at high risk of skin cancer. Organ transplant recipients’ use of sunscreen, hats, and/or long sleeves when outdoors was surveyed at enrollment in the Skin Tumours and Allograft Recipients study, annually, and at study exit. Data were included for 225 study participants with a mean follow-up of 36 months.
The researchers found that patients who used multiple sun protection measures at baseline were significantly more likely to have fair complexions, to have been born in Australia, and to have undergone annual skin cancer screening during the last five years. The odds of using multiple sun protection measures increased significantly between study enrollment and exit after adjustment for these variables (odds ratio, 4.4). Compared with the increase in odds of applying sunscreen (odds ratio, 1.7), there was more of an increase in the odds of wearing long sleeves and hats (odds ratios, 3.3 and 3.6, respectively).
“These results suggest that research clinics that conduct skin cancer surveillance among organ transplant recipients offer additional educational and primary prevention advantages beyond improved access to care,” the authors write.
Abstract/Full Text (subscription or payment may be required)
Early Complications Common in Older Kidney Transplant Recipients
Cirrhosis Can Recur After Liver Transplant
Biomarkers Plus Kidney Donor Profile Index Improve Prediction of Concordant Allograft Outcomes
Short-Term Pretransplant Dialysis Does Not Affect Kidney Transplant Outcomes
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria
1997 to 2022 Saw Increase in Pediatric Hospitalizations With AKI
Frailty Linked to Incident Cognitive Decline in Men With CKD